1 / 46

Symptom Control: Agitation and Delirium

Symptom Control: Agitation and Delirium. AOA OMED Conference San Francisco 2010. Acknowledgement. We gratefully acknowledge the outstanding work done by: Scott A. Irwin, MD, PhD Rosene P. Pirrello, RPh Jeremy M. Hirst, MD Gary T. Buckholz, MD Frank D. Ferris, MD, FAAHPM

bud
Download Presentation

Symptom Control: Agitation and Delirium

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Symptom Control: Agitation and Delirium AOA OMED Conference San Francisco 2010

  2. Acknowledgement We gratefully acknowledge the outstanding work done by: • Scott A. Irwin, MD, PhD • Rosene P. Pirrello, RPh • Jeremy M. Hirst, MD • Gary T. Buckholz, MD • Frank D. Ferris, MD, FAAHPM And the Institute for Palliative Medicine at San Diego Hospice, and AAHPM

  3. Objectives • Identify the patient at risk for agitation and delirium • Describe how to relieve suffering and control agitation and delirium

  4. Delirium is Change in mental status. Impaired: • Attention • Orientation • Cognition • Consciousness • Reality • Behavior

  5. DSM-IV Criteria Delirium 1. Disturbance in consciousness • Attention 2. Change in cognition • Examples: memory, orientation, language 3. Develops over a short period of time 4. Caused by the direct physiological consequences of a general medical condition

  6. Delirium Subtypes • Hyperactive: confusion, agitation hallucinations, myoclonus • Hypoactive: confusion, somnolence, withdrawn. More likely to be under diagnosed “If you don’t look for it, you won’t find it” • Mixed

  7. Prevalence • Hospitalized elderly: 14-56% • ICU: 70-87% • Advanced Cancer 25-85% or End of Life:

  8. Consequences • Six month mortality: up to 25% • Increased mortality: 10-78% • Prolonged hospitalizations • Stress • Discomfort • Reduced quality of life

  9. Consequences • Causes a person to be frightened, agitated and upset • Interferes with the assessment and treatment of other symptoms • Increased caregiver burden • Increases the use of restraints • Interferes with meaningful communication and interaction

  10. Patients at Risk for Delirium • Decreased oral intake: dehydration, malnutrition • Over age 65 • Male • Low activity level • Constipation/fecal impaction • History of falls • Visual or hearing impairment • Depression • History of previous delirium

  11. Causes Delirium has many, many causes – A good number of them are discoverable and reversible – approximately 50%

  12. J.O.M.A.C. Mnemonic • J – JUDGEMENT changes • O – ORIENTATION changes • M – MEMORY changes • A – AFFECT changes • C – COGNITIVE changes • Delirium is a state defined by a CHANGE in mental functioning

  13. Most Common Causes • Fluid imbalance • Medications (see next slide) • Infections • Hepatic or renal failure • Hypoxia • Hematological disturbances

  14. Medication Side Effect (most common) • Opioids • Corticosteroids • Benzodiazepines • Scopolamine • Hydroxyzine • Diphenhydramine • Hyoscyamine • Tricyclic-Antidepressants • H2 Blockers • NSAIDS • Metoclopramide • Alcohol/drug withdrawal

  15. Often Under-Recognized In a hospice study of 2700 patients (S.A. Irwin et.al.2008) delirium was recognized in only: • 17.8% of home care patients • 28.3 % of inpatients

  16. Why Under-Recognized • Complex presentation • Inconsistent language among professionals about mental status • Preconceived notions • Hypo-active sub-type is quiet • Thought to be normal part of end of life

  17. Address Existential Causes • Involve the chaplain • Assess for possible existential crisis or other version of pre-death awareness • Consider prayer, meditation, mantra, ritual

  18. Delirium May be Mistaken for Pain • If grimacing and agitation are thought to be pain, assess the cause. If there is no obvious reason for the pain, or the pain is “all over”, it is probably delirium • Frequently, the delirious pt will answer “yes” to the question of pain • An opioid may sedate a delirious pt, leading to the belief that it has helped

  19. Delirium May be Mistaken for Anxiety, Depression, or Dementia • Anxiety: apprehension, jitters, etc. but attentive, alert and oriented • Depression: may be restless with decreased concentration but attentive and oriented • Dementia: usually alert, and attentive, decreased cognition over months to years

  20. Comparison: Delirium vs Dementia Delirium • Acute onset • Fluctuates • Duration days to weeks • Altered consciousness • Impaired attention • Increased or decreased psychomotor • Can be reversible Dementia • Insidious onset • Progressive • Duration months to years • Clear consciousness • Normal attention except when severe • Normal psychomotor (usually) • Rarely reversible

  21. Comparison: Delirium vs. Sundown Syndrome Delirium • Change in alertness • Onset – hours to days • Fluctuates hourly Sundown Syndrome • No change in alertness • Onset – daily, slowly worsening • Fluctuation daily and predictable • Occurs with dementia

  22. Treatment

  23. Identify Reversible Causes of Delirium Time limited trial to find and reverse the causes such as • Drug side effects • Low oxygen – CHF, COPD, PE • Infection • Retention of urine or feces • Poor intake – malnutrition, dehydration • Organ failure – kidney, liver • Metabolic problems – electrolytes, thyroid, Ca++ 

  24. Terminal Delirium • This is delirium during the dying process when there is not a reversible cause and the patient is expected to die in the following hours, days to a week • Frequently there is restlessness, agitation, moaning, and purposeless vocalization. • Signs of active dying process may be present, such as peripheral cooling, abnormal breathing, anuria, etc.

  25. Non-pharmacologic Management of Delirium Provide support and orientation: • Communicate clearly, concisely, and calmly • Give repeated verbal reminders of the day, time and location • Provide clear signposts to patient’s location, including clock and date • Have familiar objects from the patient’s home nearby

  26. Non-pharmacologic Management of Delirium Provide an unambiguous environment: • Try to avoid frequent change in bed location • Avoid using medical jargon in front of the patient • Avoid extremes of bright lighting and darkness • Control excess noise • Keep room temperature between 70-75 degrees.

  27. Non-pharmacologic Management of Delirium Maintaining competence: • Identify and correct sensory impairments. Ensure patients have their glasses, hearing aid and dentures • Use an interpreter as needed • Encourage self care and participation in treatment

  28. Non-pharmacologic Management of Delirium • Have patient/caregiver give feedback on treatments of symptoms • Maintain activity levels; and arrange treatments to allow for maximum periods of un-interrupted sleep.

  29. Pharmacologic Management of Delirium

  30. Pharmacologic Management of Delirium Hyperactive delirium • Haloperidol (Haldol) is drug of choice for symptom of agitation (or other symptom causing suffering) • Haloperidol is a butyrophenone derivative with antipsychotic properties that has been considered particularly effective in the management of hyperactivity, agitation, and mania. • Haloperidol is an effective neuroleptic and also possesses antiemetic properties

  31. Haloperidol (Haldol) • Haldol is NOT for use in alcohol or benzodiazepine withdrawal • Check to see if the patient has Parkinson’s Disease prior to initiating it • There may be a slightly increased risk of serious side effects (e.g., pneumonia and heart failure) when used in older adults with dementia.

  32. Haloperidol (Haldol) Second generation medications such as • chlorpromazine (thorazine) • olanzapine (zyprexa) • quetiapine (seroquel) • risperidone (risperdol) may be needed if haldol alone is not effective

  33. Pharmacologic Management of Delirium Hypoactive delirium • Medication for hypoactive delirium is not usually needed Mixed delirium • Medication as per hyperactive delirium with less during hypoactive part of the day

  34. Pharmacologic Management of Delirium Terminal delirium • Sedation is the main treatment and • Benzodiazepines are more important (examples of benzodiazepines are ativan, xanax, librium, valium)

  35. Reassessment • If there is not adequate relief of suffering, try further non-pharmacologic comfort measures. • Treat agitation like a breakthrough symptom (pain) and use PRN medication • If the pharmacologic treatment is not effective in relieving suffering, the physician should be notified for further orders.

  36. Medication Side Effects • Observe for medication side effect • Note the varying degree of sedation and extra-pyramidal symptoms that different drugs have

  37. Medication Side Effects *EPS: Extra-pyramidal Symptoms (Parkinsonian-like)

  38. Extra-pyramidal Symptoms (EPS) EPS are movement disorders that can occur as a result of taking haldol (or other anti-psychotic drugs). Examples: • Tardive dyskinesia -involuntary, irregular muscle movements, usually in the face • Muscular lead-pipe rigidity • Bradykinesia – slow movement • Akinesia – inability to initiate movement • Resting tremor • Postural instability

  39. Lorezapam (Ativan) Indicated for • Delirium due to alcohol and benzodiazepine withdrawal • Anxiety • Primal fear (e.g., feeling of suffocation) • Sedation therapy (use with haldol for delirium) • Seizure disorder

  40. Lorazepam (Ativan) • Like all drugs in this chemical family, (i.e. benzodiazepines), lorazepam enhances the action of the inhibitory neurotransmitter GABA by acting at the GABAA receptor. • It has anxiolytic, sedative and hypnotic properties

  41. Toxicity with Ativan • Respiratory depression, especially if opioids are present • May worsen delirium • Over sedation when treating delirium

  42. Nursing Home Quality of Care – F tags CMS Nursing Home surveys include audit and review of • F-329 Unnecessary drugs used • F-330 Antipsychotics received when appropriate • F-331 Antipsychotics dose reduction Documentation needs to focus on the symptoms causing suffering, and the interventions, both non-pharmacologic and pharmacologic that have been used to help relieve symptoms

  43. Nursing Implications • Provide support and orientation • Provide an unambiguous environment • Help the patient maintain competence, function and activities as much as he is able • Observe for medication side effects • Address safety issues and implement fall prevention strategies, especially for patients with agitation

  44. Goal: Early Diagnosis, Assessment and Treatment • Order appropriate laboratory and diagnostic studies to assess for reversible causes • Include non-pharmacologic interventions in the Plan of Care • Prescribe pharmacologic treatment for the suffering and symptoms of delirium if indicated

  45. Case Study • Anna is a 78 yr female, primary diagnosis non-small cell lung carcinoma • Right lobectomy two years ago • Maintained on continuous O2 @1.5 L/min • Lives at home alone • Usually alert and oriented

  46. Film clip

More Related